Loading...

Pfizer Inc.

PFE.FXETRA
Healthcare
Drug Manufacturers - General
22.96
-0.02(-0.09%)
German Market opens in 9h 23m

Pfizer Inc. (PFE.F) Stock Competitors & Peer Comparison

See (PFE.F) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - General Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
PFE.F€22.96-0.09%131.5B19.76€1.17+6.36%
LLY.DE€772.20-2.61%729.6B39.26€19.67+0.68%
JNJ.DE€201.50-1.27%485.3B21.50€9.37+2.18%
4AB.DE€175.40-0.71%310.2B86.83€2.02+3.24%
ZEG.DE€160.70+0.59%249.2B28.75€5.59+1.69%
6MK.DE€99.45-2.40%245.9B15.94€6.24+2.79%
AMG.DE€293.20-1.30%158.1B23.99€12.22+2.78%
GIS.DE€117.60-1.23%146B20.28€5.80+2.30%
PFE.DE€22.96-0.69%130.6B19.79€1.16+6.35%
BRM.DE€48.86-1.51%99.7B16.51€2.96+4.32%
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

PFE.F vs LLY.DE Comparison April 2026

PFE.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.F stands at 131.5B. In comparison, LLY.DE has a market cap of 729.6B. Regarding current trading prices, PFE.F is priced at €22.96, while LLY.DE trades at €772.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.F currently has a P/E ratio of 19.76, whereas LLY.DE's P/E ratio is 39.26. In terms of profitability, PFE.F's ROE is +0.09%, compared to LLY.DE's ROE of +0.98%. Regarding short-term risk, PFE.F is less volatile compared to LLY.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PFE.F.Check LLY.DE's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions